Gemtuzumab ozogamicin for untreated acute myeloid leukaemia

Final appraisal determination

Final appraisal determination document (PDF 550 KB)

Committee papers (PDF 560 KB)

Draft guidance: 1

Appraisal consultation document (PDF 458 KB)

Committee papers (PDF 16.92 MB)

Final scope (PDF 222 KB)

Final matrix (PDF 262 KB)

NICE's response to comments on the draft scope and provisional matrix (PDF 335 KB)

Equality impact assessment (Scoping) (PDF 176 KB)

Final scope Issued March 2018 (PDF 224 KB)

NICE's response to comments on the draft scope and provisional matrix Issued March 2018 (PDF 246 KB)